GLP-1 controls appetite, stimulates glucose-dependent insulin release, suppresses glucagon, and slows gastric emptying, which is why it underpins weight-loss and diabetes drugs
Intracellular lipid metabolism and homeostasis are regulated by SREBPs, of which SREBP1 is a gene that controls lipid synthesis, and SREBP2 is a gene that controls cholesterol-related metabolism
Cardiovascular disease accounts for approximately 50% of deaths in the ESRD population, and complications of left ventricular dysfunction and left ventricular hypertrophy lead to considerable morbidity
Clinical evidence suggests that when you administer your weekly injection or take your daily oral dose can influence both efficacy and tolerability, though the medication itself works consistently throughout the seven-day window after injection
The personal injury attorneys at McWhirter, Bellinger & Associates are reviewing potential GLP-1 drug lawsuits following reports of serious gastrointestinal side effects including gastroparesis, pancreatitis, and ileus
But you'll probably stop taking tirzepatide and start on a low dose of semaglutide that gradually increases even if you were on a high dose of tirzepatide
